Uric Acid-Lowering Benefit of Lesinurad Confirmed
Combination therapy with lesinurad and allopurinol increases the percentage of gout patients who achieve target serum uric acid levels, a benefit that persists for least 2 years, according to the findings of an extension study presented at the annual meeting of the American College of Rheumatology in Washington, DC....

http://www.renalandurologynews.com/hyperuricemia/uric-acid-lowering-benefit-of-lesinurad-confirmed/article/572631/
Like
Comment
Share